HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eun Ji Kim Selected Research

sphingosine phosphorylcholine

3/2017Novel involvement of RhebL1 in sphingosylphosphorylcholine-induced keratin phosphorylation and reorganization: Binding to and activation of AKT1.
6/2016Epithelial membrane protein 2 regulates sphingosylphosphorylcholine-induced keratin 8 phosphorylation and reorganization: Changes of PP2A expression by interaction with alpha4 and caveolin-1 in lung cancer cells.
3/2016Novel effects of FTY720 on perinuclear reorganization of keratin network induced by sphingosylphosphorylcholine: Involvement of protein phosphatase 2A and G-protein-coupled receptor-12.
1/2016Novel effects of sphingosylphosphorylcholine on invasion of breast cancer: Involvement of matrix metalloproteinase-3 secretion leading to WNT activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eun Ji Kim Research Topics

Disease

34Neoplasms (Cancer)
10/2023 - 08/2003
11Colonic Neoplasms (Colon Cancer)
04/2015 - 07/2002
10Neoplasm Metastasis (Metastasis)
10/2023 - 12/2009
7Breast Neoplasms (Breast Cancer)
10/2023 - 08/2011
7Prostatic Neoplasms (Prostate Cancer)
06/2014 - 01/2006
6Carcinoma (Carcinomatosis)
10/2023 - 01/2006
6Infections
08/2023 - 01/2019
6COVID-19
10/2022 - 01/2020
6Lung Neoplasms (Lung Cancer)
10/2021 - 06/2016
5Obesity
02/2022 - 08/2011
4Stomach Neoplasms (Stomach Cancer)
04/2024 - 06/2011
4Body Weight (Weight, Body)
12/2023 - 09/2015
4Inflammation (Inflammations)
08/2023 - 07/2010
4Carcinogenesis
06/2014 - 07/2002
3Cardiovascular Diseases (Cardiovascular Disease)
12/2022 - 12/2013
2Osteoarthritis
03/2024 - 10/2021
2Sarcopenia
03/2023 - 07/2022
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2022 - 06/2012
2Parkinson Disease (Parkinson's Disease)
09/2022 - 09/2014
2Non-alcoholic Fatty Liver Disease
07/2022 - 05/2013
2Stroke (Strokes)
04/2022 - 06/2012
2Melanoma (Melanoma, Malignant)
03/2022 - 09/2015
2Hypoxia (Hypoxemia)
10/2021 - 01/2013
2Fibrosis (Cirrhosis)
12/2020 - 01/2016
2Wounds and Injuries (Trauma)
01/2020 - 01/2016
2Hepatocellular Carcinoma (Hepatoma)
02/2018 - 11/2008
2Hypertension (High Blood Pressure)
01/2018 - 06/2014
2Cicatrix (Scar)
03/2017 - 01/2016
2Adenocarcinoma
01/2014 - 02/2011
2Leukemia
12/2011 - 12/2007
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2023
1Erythema
08/2023
1Hemoptysis
08/2023

Drug/Important Bio-Agent (IBA)

6Ethanol (Ethyl Alcohol)IBA
12/2023 - 06/2014
5Proteins (Proteins, Gene)FDA Link
10/2023 - 04/2015
5AntioxidantsIBA
08/2023 - 11/2008
5Conjugated Linoleic AcidsIBA
04/2006 - 07/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2023 - 11/2011
4LipidsIBA
12/2020 - 08/2011
4Keratins (Keratin)IBA
05/2018 - 01/2016
4sphingosine phosphorylcholineIBA
03/2017 - 01/2016
4Death Domain ReceptorsIBA
06/2011 - 10/2009
3Messenger RNA (mRNA)IBA
03/2024 - 01/2020
3Therapeutic UsesIBA
11/2022 - 06/2012
3Phosphotransferases (Kinase)IBA
07/2022 - 01/2005
3Biomarkers (Surrogate Marker)IBA
08/2021 - 11/2014
3Keratin-8 (Keratin 8)IBA
05/2018 - 03/2016
3SteroidsIBA
01/2015 - 01/2011
3EnzymesIBA
08/2011 - 01/2007
33,3'-diindolylmethane (diindolylmethane)IBA
02/2011 - 12/2009
31,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
04/2006 - 07/2002
2Interleukin-6 (Interleukin 6)IBA
03/2024 - 01/2013
2Iodoacetic AcidIBA
03/2024 - 10/2021
2Macrophage Colony-Stimulating FactorIBA
10/2023 - 08/2011
2Mannose ReceptorIBA
10/2023 - 09/2015
2Triglycerides (Triacylglycerol)IBA
12/2022 - 05/2013
2HDL CholesterolIBA
12/2022 - 05/2013
2Interferon Type IIBA
10/2022 - 03/2021
2Glucose (Dextrose)FDA LinkGeneric
09/2022 - 01/2013
2Hypoglycemic Agents (Hypoglycemics)IBA
07/2022 - 02/2022
2VimentinIBA
10/2021 - 12/2016
2RNA (Ribonucleic Acid)IBA
10/2021 - 06/2017
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2021 - 01/2012
2Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2021 - 01/2020
2tegoprazanIBA
01/2021 - 01/2020
2AcidsIBA
01/2021 - 01/2020
2PotassiumIBA
01/2021 - 01/2020
2oxidized low density lipoproteinIBA
01/2020 - 01/2020
2Matrix Metalloproteinases (MMPs)IBA
01/2020 - 12/2009
2Complement System Proteins (Complement)IBA
01/2020 - 08/2011
2Cell Adhesion MoleculesIBA
01/2020 - 08/2011
2LDL CholesterolIBA
01/2020 - 01/2020
2Antiviral Agents (Antivirals)IBA
01/2020 - 01/2019
2oligochitosanIBA
01/2019 - 05/2018
2Cytochromes c (Cytochrome c)IBA
04/2017 - 10/2006
2Small Interfering RNA (siRNA)IBA
06/2016 - 09/2015
2urushiolIBA
07/2014 - 05/2013
2dehydrocostus lactoneIBA
01/2012 - 12/2008
2benzyl isothiocyanateIBA
01/2012 - 11/2011
2HexanesIBA
01/2012 - 12/2008
2Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2011 - 02/2011
2CytokinesIBA
08/2011 - 12/2009
2DNA (Deoxyribonucleic Acid)IBA
01/2011 - 08/2003
2AndrogensIBA
10/2009 - 12/2008
2isoliquiritigenin (GU 17)IBA
10/2006 - 01/2006
2IGF Type 1 Receptor (IGF 1 Receptor)IBA
01/2005 - 08/2003
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2024
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
03/2024
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2024
1Anti-Bacterial Agents (Antibiotics)IBA
11/2023
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2023
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2023
1TeaIBA
10/2023
1Platelet Endothelial Cell Adhesion Molecule-1IBA
10/2023
1Melanins (Melanin)IBA
08/2023

Therapy/Procedure

6Therapeutics
08/2023 - 01/2019
2Gastrectomy
04/2024 - 12/2012
2Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2018 - 01/2012
2Oral Administration
11/2011 - 12/2009
1Drug Therapy (Chemotherapy)
08/2023